End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.285 CAD | 0.00% |
|
+14.00% | -51.69% |
Jun. 26 | Transcript : The Cannabist Company Holdings Inc. - Shareholder/Analyst Call | |
Jun. 26 | The Cannabist Company and Bloom Introduce Vape Brand to New East Coast Markets | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
Weaknesses
- Low profitability weakens the company.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-51.69% | 97.05M | C | ||
+13.17% | 228M | - | ||
-14.43% | 177M | - | ||
+34.30% | 176M | C | ||
-28.57% | 122M | - | - | |
+300.00% | 121M | - | - | |
+32.46% | 120M | - | ||
+92.14% | 112M | - | - | |
+7.69% | 94.1M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
- Stock Market
- Equities
- CBSTF Stock
- CBST Stock
- Ratings The Cannabist Company Holdings Inc.